Laurion Capital Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-19,302
| Closed | -$132K | – | 286 |
|
|
2024
Q2 | $132K | Buy |
+19,302
| New | +$132K | ﹤0.01% | 381 |
|
|
2023
Q4 | – | Sell |
-11,012
| Closed | -$37.4K | – | 283 |
|
|
2023
Q3 | $37.4K | Buy |
+11,012
| New | +$37.4K | ﹤0.01% | 228 |
|
|
2019
Q4 | – | Sell |
-7,200
| Closed | -$376K | – | 578 |
|
|
2019
Q3 | $376K | Buy |
+7,200
| New | +$376K | ﹤0.01% | 434 |
|
|
2017
Q3 | – | Sell |
-6,311
| Closed | -$214K | – | 1138 |
|
|
2017
Q2 | $214K | Buy |
+6,311
| New | +$214K | ﹤0.01% | 1054 |
|